Prevalence of fibromyalgia and associated factors in Spain

The prevalence of fibromyalgia (FM) differs depending on the population studied. The main objective of the EPISER2016 study was to estimate the prevalence of FM in adults in Spain. The secondary objective was to evaluate the association with sociodemographic and anthropometric characteristics and sm...

Full description

Saved in:
Bibliographic Details
Published inClinical and experimental rheumatology Vol. 38 Suppl 123; no. 1; p. 47
Main Authors Font Gayà, Teresa, Bordoy Ferrer, Carolina, Juan Mas, Antonio, Seoane-Mato, Daniel, Álvarez Reyes, Fatima, Delgado Sánchez, Mónica, Martínez Dubois, Cristina, Sánchez-Fernández, Simon A, Marena Rojas Vargas, Luisa, García Morales, Paula V, Olivé, Alejandro, Rubio Muñoz, Paula, Larrosa, Marta, Navarro Ricós, Noemí, Sánchez-Piedra, Carlos, Díaz-González, Federico, Bustabad-Reyes, Sagrario
Format Journal Article
LanguageEnglish
Published Italy 01.01.2020
Online AccessGet more information

Cover

Loading…
More Information
Summary:The prevalence of fibromyalgia (FM) differs depending on the population studied. The main objective of the EPISER2016 study was to estimate the prevalence of FM in adults in Spain. The secondary objective was to evaluate the association with sociodemographic and anthropometric characteristics and smoking. This is a population-based cross-sectional multicentre study. The random selection was based on multistage stratified cluster sampling. The final sample comprised 4916 persons aged ≥20 years. Participants were contacted by telephone for completion of a screening survey. Investigating rheumatologists evaluated positive results (review of medical records and/or telephone interview, with medical visit if needed) to confirm the diagnosis. Prevalence and 95% confidence interval were calculated, taking into account the sample design. Weighing was applied based on age, sex, and geographic origin. Predictive models were constructed to analyse which sociodemographic, anthropometric and lifestyle variables in the call centre questionnaire were associated with the presence of FM. 602 subjects (12.25%) had a positive screening result for FM, of which 24 were missing (3.99%). A total of 141 cases of FM were recorded. The estimated prevalence was 2.45% (95% CI, 2.06-2.90). Female sex was the variable most associated with FM, with an odds ratio (OR) of 10.156 (95% CI, 5.068-20.352). Peak prevalence was at 60-69 years (p=0.009, OR=6.962). FM was 68% more frequent in obese individuals (OR, 1.689; 95% CI, 1.036-2.755). The prevalence of FM in adults in Spain barely changed between 2000 and 2016 and it is similar to that observed in Europe as a whole.
ISSN:0392-856X